Associated Papers
Identifying active and inhibitor-resistant MGMT variants for gene therapy.
Cheong A et al.
American Journal of Human Genetics, 2025
O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma.
Ma S et al.
British Journal of Cancer, 2003
[Mutation of human O6-alkylguanine-DNA alkyltransferase confers resistance to O6-benzylguanine].
Wan Y et al.
Zhonghua Zhong Liu Za Zhi [chinese Journal of Oncology], 2000
Protection of hematopoietic cells against combined O6-benzylguanine and chloroethylnitrosourea treatment by mutant forms of O6-methylguanine DNA methyltransferase.
Williams DA et al.
Bone Marrow Transplantation, 2000
Active and alkylated human AGT structures: a novel zinc site, inhibitor and extrahelical base binding.
Daniels DS et al.
The Embo Journal, 2000
Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O6-methylguanine DNA methyltransferase protects hematopoietic cells against O6-benzylguanine sensitization to chloroethylnitrosourea treatment.
Maze R et al.
The Journal of Pharmacology and Experimental Therapeutics, 1999
Select a paper to view details